Drug profile · INN
sulfisoxazole acetyl
GANTRISIN PEDIATRIC
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sulfisoxazole acetyl (GANTRISIN PEDIATRIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sulfisoxazole acetyl
Brand GANTRISIN PEDIATRIC
Route ORAL
Formulation EMULSION
Frequently asked questions
What is sulfisoxazole acetyl?
sulfisoxazole acetyl (GANTRISIN PEDIATRIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sulfisoxazole acetyl?
GANTRISIN PEDIATRIC is a marketed brand name for sulfisoxazole acetyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfisoxazole acetyl?
sulfisoxazole acetyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.